期刊
IMMUNOTHERAPY
卷 11, 期 6, 页码 461-466出版社
FUTURE MEDICINE LTD
DOI: 10.2217/imt-2019-0021
关键词
atezolizumab; avelumab; checkpoint inhibitors; durvalumab; ipilimumab; nivolumab; non-small-cell lung cancer; pembrolizumab
类别
分享论文
